Guest editorial: basic and clinical updates in multiple myeloma.

Suppr

超能文献

作者信息

Kizaki Masahiro

出版信息

Int J Hematol. 2013 Mar;97(3):304-5. doi: 10.1007/s12185-013-1292-1. Epub 2013 Feb 19.

DOI:10.1007/s12185-013-1292-1

PMID:23420182

Abstract

摘要

相似文献

Guest editorial: basic and clinical updates in multiple myeloma.

Int J Hematol. 2013 Mar;97(3):304-5. doi: 10.1007/s12185-013-1292-1. Epub 2013 Feb 19.

Influencing the Wnt signaling pathway in multiple myeloma.

Anticancer Res. 2011 Feb;31(2):725-30.

Molecular mechanisms of novel therapeutic approaches for multiple myeloma.

Nat Rev Cancer. 2002 Dec;2(12):927-37. doi: 10.1038/nrc952.

[Advances in the study of hematopoietic cell apoptosis in multiple myeloma].

Zhonghua Xue Ye Xue Za Zhi. 1999 Jun;20(6):334-6.

When to initiate treatment in smoldering multiple myeloma.

Clin Adv Hematol Oncol. 2017 Oct;15(10):751-753.

Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.

Best Pract Res Clin Haematol. 2007 Dec;20(4):665-80. doi: 10.1016/j.beha.2007.10.002.

[Multiple myeloma].

Dtsch Med Wochenschr. 2012 Mar;137 Suppl 1:S14-7. doi: 10.1055/s-0032-1301853. Epub 2012 Mar 21.

Editorial Expression of Concern: RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells.

Oncogene. 2024 Sep;43(40):3019. doi: 10.1038/s41388-024-03152-8.

CD52 expression patterns in myeloma and the applicability of alemtuzumab therapy.

Haematologica. 2006 Nov;91(11):1577-8. Epub 2006 Oct 17.

[Human plasmacytoma from biology to clinical practice].

Nouv Rev Fr Hematol (1978). 1993 Jun;35(3):179-82.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Guest editorial: basic and clinical updates in multiple myeloma.

Int J Hematol. 2013 Mar;97(3):304-5. doi: 10.1007/s12185-013-1292-1. Epub 2013 Feb 19.

Influencing the Wnt signaling pathway in multiple myeloma.

Anticancer Res. 2011 Feb;31(2):725-30.

Molecular mechanisms of novel therapeutic approaches for multiple myeloma.

Nat Rev Cancer. 2002 Dec;2(12):927-37. doi: 10.1038/nrc952.

[Advances in the study of hematopoietic cell apoptosis in multiple myeloma].

Zhonghua Xue Ye Xue Za Zhi. 1999 Jun;20(6):334-6.

When to initiate treatment in smoldering multiple myeloma.

Clin Adv Hematol Oncol. 2017 Oct;15(10):751-753.

Multiple myeloma: new staging systems for diagnosis, prognosis and response evaluation.

Best Pract Res Clin Haematol. 2007 Dec;20(4):665-80. doi: 10.1016/j.beha.2007.10.002.

[Multiple myeloma].

Dtsch Med Wochenschr. 2012 Mar;137 Suppl 1:S14-7. doi: 10.1055/s-0032-1301853. Epub 2012 Mar 21.

Editorial Expression of Concern: RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells.

Oncogene. 2024 Sep;43(40):3019. doi: 10.1038/s41388-024-03152-8.

CD52 expression patterns in myeloma and the applicability of alemtuzumab therapy.

Haematologica. 2006 Nov;91(11):1577-8. Epub 2006 Oct 17.

[Human plasmacytoma from biology to clinical practice].

Nouv Rev Fr Hematol (1978). 1993 Jun;35(3):179-82.